GLP-1 Research: Advances, Mechanisms, and Future Directions Glucagon-like peptide-1 (GLP-1) research has shifted from a niche interest in diabetes to a central topic in metabolic and neurological science
Maintaining adequate hydration and promptly reporting symptoms such as decreased urination, dark urine, or persistent dizziness to your healthcare provider is important for kidney safety monitoring
Ingelfinger, MD, from @TuftsMedSchool and the Maine Medical Center Institute for Research: nejm.org/doi/full/10.10 - Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong evidence to support their use in fact, they have presaged a mini-revolution in how type 2 diabetes is managed
however, as HF progresses, myocardial VIP depletion occurs
As expected, a GLP-1(2836)induced cAMP response was preserved in control siRNAtransfected cells (42.2 1 vs
The published preclinical literature characterises BPC-157 primarily in three research areas